Telpegfilgrastim for chemotherapy-induced neutropenia in patients with non-small cell lung cancer: a...
Telpegfilgrastim for chemotherapy-induced neutropenia in patients with non-small cell lung cancer: a multicentre, randomized, phase 3 study
About this item
Full title
Author / Creator
Shi, Yuankai , Wang, Xinshuai , Pei, Zhidong , Shi, Huaqiu , Zhang, Yanjun , Yi, Tienan , Mei, Jiazhuan , Guo, Yanzhen , Dong, Youhong , Ma, Tianjiang , Zhang, Qingyuan , Jia, Xiaojing , Zhu, Zhengqiu , Xu, Shen , Liu, Yanyan , Niu, Hongrui , Jiang, Weimei , Jiang, Xiaodong , Zhou, Shengyu and Sun, Li
Publisher
England: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
Chemotherapy-induced neutropenia (CIN) is usually managed by recombinant human granulocyte colony stimulating factor (rhG-CSF) and pegylated rhG-CSF (PEG-rhG-CSF). This study evaluated the efficacy and safety of telpegfilgrastim, a novel Y-shaped PEG-rhG-CSF, for CIN prophylaxis in patients with non-small cell lung cancer (NSCLC).
This was a mul...
Alternative Titles
Full title
Telpegfilgrastim for chemotherapy-induced neutropenia in patients with non-small cell lung cancer: a multicentre, randomized, phase 3 study
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_a0c1b1a36b3b4833ba4e1e00f5166226
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_a0c1b1a36b3b4833ba4e1e00f5166226
Other Identifiers
ISSN
1471-2407
E-ISSN
1471-2407
DOI
10.1186/s12885-025-13736-6
